Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Intercept Pharmaceuticals, Inc. (ICPT)

« Back to company index

ICPT Chatter Timeline

Stock Ticker for ICPT

Most Active Tweeters for ICPT

UserTweets
@smelky_kid 14
@sleekoptions 10
@okim59 7
@AmericanBanking 6
@ZolmaxNews 5

Recent Tweets for ICPT

okim59 @okim59
While expected, Intercept's approval delay adds to NASH uncertainty | BioPharma Dive $ICPT https://t.co/0sQEZNdABd
January 17th 2020, 5:01pm
ResearchPool @ResearchPool
$ICPT #Intercept Pharmaceuticals Inc Weekly Symphony Health Estimates for OCALIVA®: | https://t.co/rOCMZ4a9di… https://t.co/G1EUBNFs4S
January 17th 2020, 3:01pm
VBelhelen @VBelhelen
RT @okim59: $ICPT January 15, 2020, the FDA notified the Company that, pursuant to a major amendment, the FDA has extended the PDUFA target…
January 17th 2020, 3:01pm
OfficialDonsino @OfficialDonsino
$ICPT Picked up 800 @ $106
January 17th 2020, 1:01pm
VBelhelen @VBelhelen
RT @EpiscopalianTra: $ICPT No wonder it's been going down since Monday. Somebody knew this... but *Intercept 8-K Shows FDA Notified Co. O…
January 17th 2020, 1:01pm
WallStreet_Wire @WallStreet_Wire
Intercept Pharmaceuticals $ICPT says FDA extends PDUFA target action date to June 26, 2020 https://t.co/VZyl4bW78P… https://t.co/A0Gl4yGZG2
January 17th 2020, 1:01pm
SwingTradeBot @SwingTradeBot
Fell Below 50 DMA today: $ICPT ... https://t.co/j2lcQOTpfA
January 17th 2020, 1:01pm
NedPagliarulo @NedPagliarulo
Intercept's waiting game just got a little longer, @realJacobBell writes, with comments from CEOs of $ICPT, $VKTX a… https://t.co/Ft6FZV6EaN
January 17th 2020, 12:01pm
Olemaire78 @Olemaire78
RT @svKatface: JMP's Liisa Bayko comments on $ICPT and PDUFA news; continues to recommend Intercept shares and maintains Outperform rating…
January 17th 2020, 11:01am
svKatface @svKatface
Bayko, per Tipranks. 14.5% average return per each rating - that aint bad! $ICPT https://t.co/tnwRGC9wP3
January 17th 2020, 10:01am
svKatface @svKatface
JMP's Liisa Bayko comments on $ICPT and PDUFA news; continues to recommend Intercept shares and maintains Outperfor… https://t.co/FWUxOKZsGq
January 17th 2020, 10:01am
MSollender @MSollender
RT @bio_clouseau: As expected $ICPT PDUFA extended to 6/26
January 17th 2020, 10:01am
okim59 @okim59
$ICPT January 15, 2020, the FDA notified the Company that, pursuant to a major amendment, the FDA has extended the… https://t.co/5yvoetsdEG
January 17th 2020, 9:01am
EpiscopalianTra @EpiscopalianTra
$ICPT No wonder it's been going down since Monday. Somebody knew this... but *Intercept 8-K Shows FDA Notified Co… https://t.co/72uZAa8R2I
January 17th 2020, 9:01am
NicholasTessing @NicholasTessing
$ICPT JMP Securities stating that the updated PDUFA date is consistent with her timelines. OCA remains the only dru… https://t.co/XWPRNel8wX
January 17th 2020, 9:01am
NedPagliarulo @NedPagliarulo
RT @realJacobBell: FDA extending PDUFA date for $ICPT ‘s OCA in NASH to June 26. Co. says it was notified on Jan. 15 https://t.co/t55kUYo8O9
January 17th 2020, 9:01am
ShareyShareson @ShareyShareson
$ICPT farewell, all. I’m finally selling up after several years, with a good profit on the holdings I have. Anyone… https://t.co/ZJciVN3AwM
January 17th 2020, 9:01am
NicholasTessing @NicholasTessing
@_B_I_O_T_E_C_H_ $ICPT What the heck is the point of priority review then? Why even offer it?
January 17th 2020, 8:01am
7LadyQ @7LadyQ
$ICPT BRIEF-Intercept Pharmaceuticals -On Jan 15,FDA Notified Co That, Pursuant To A Major Amendment, FDA Has Exten… https://t.co/EZ3NVAh5B5
January 17th 2020, 8:01am
Tootix @Tootix
RT @_B_I_O_T_E_C_H_: $ICPT On Jan 15,FDA Notified Co That, Pursuant To A Major Amendment, FDA Has Extended PDUFA Target Action Date To June…
January 17th 2020, 8:01am
realJacobBell @realJacobBell
FDA extending PDUFA date for $ICPT ‘s OCA in NASH to June 26. Co. says it was notified on Jan. 15 https://t.co/t55kUYo8O9
January 17th 2020, 8:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$ICPT On Jan 15,FDA Notified Co That, Pursuant To A Major Amendment, FDA Has Extended PDUFA Target Action Date To June 26
January 17th 2020, 8:01am
bio_clouseau @bio_clouseau
As expected $ICPT PDUFA extended to 6/26
January 17th 2020, 8:01am
sleekoptions @sleekoptions
$ICPT - Last six months, 13 option alerts peaked above 100% after they were triggered by the algo… https://t.co/yzomWd91g9
January 16th 2020, 12:01pm
okim59 @okim59
Intercept’s CEO talks payers, pruritis, and price - STAT $ICPT #NASH https://t.co/b7sLUKsiLA
January 16th 2020, 12:01pm
sleekoptions @sleekoptions
Peak profit for the last 6 expired option alerts for $ICPT 105.56 % | -9.80 % | 204.35 % | 6.67 % | 200.45 % | 0.00… https://t.co/mgFuK9naxw
January 16th 2020, 12:01pm
stocknewstimes @stocknewstimes
Intercept Pharmaceuticals Inc $ICPT Receives $144.65 Average PT from Analysts https://t.co/huV4ZvgPdC
January 15th 2020, 9:01pm
WeekHerald @WeekHerald
Intercept Pharmaceuticals Inc $ICPT Given Average Rating of “Buy” by Analysts https://t.co/K7vz2YJ6XI
January 15th 2020, 9:01pm
NicholasTessing @NicholasTessing
@smelky_kid $icpt. Mark was certainly complementary of Gilead today. He mentioned them twice in the presentation an… https://t.co/lGWrudwImc
January 15th 2020, 5:01pm
NicholasTessing @NicholasTessing
@bio_clouseau $icpt. I gotcha, but if you listen to the presentation, he announced that enrollment is complete. So… https://t.co/SXTsSBF0mv
January 15th 2020, 5:01pm
smelky_kid @smelky_kid
@BertrandBio If $ICPT treats 100% of the targeted market, Ocaliva revenues will only be 41 Billion. Hmmm.
January 15th 2020, 3:01pm
smelky_kid @smelky_kid
@BertrandBio $ICPT Based on your number of physicians, they only need 13 patients each on drug to generate almost… https://t.co/UdndmTseLe
January 15th 2020, 3:01pm
smelky_kid @smelky_kid
@BertrandBio If $ICPT treats only 4% of the target market, OCALIVA will generate 1.7 BILLION in sales. That’s only… https://t.co/p5geH1Ut1w
January 15th 2020, 3:01pm
Tootix @Tootix
RT @BertrandBio: $ICPT expecting some NASH trials to succeed in 2020, they didn't mention any name obviously, they're skeptical abt semaglu…
January 15th 2020, 2:01pm
BertrandBio @BertrandBio
out of the 500k tgted pts, they are identified and treated by 1500-1600 physicians that $ICPT will educate, etc...
January 15th 2020, 1:01pm
BertrandBio @BertrandBio
$ICPT expecting some NASH trials to succeed in 2020, they didn't mention any name obviously, they're skeptical abt… https://t.co/tvXvutMxbo
January 15th 2020, 1:01pm
Olemaire78 @Olemaire78
RT @BertrandBio: From $ICPT #JPM20, 82% of surveyed liver specialists believe Non-Invasive Tests (like FIB-4 or Fibroscan) are ready for pr…
January 15th 2020, 1:01pm
BertrandBio @BertrandBio
From $ICPT #JPM20, 82% of surveyed liver specialists believe Non-Invasive Tests (like FIB-4 or Fibroscan) are ready… https://t.co/C0Wda9u4bH
January 15th 2020, 1:01pm
bio_clouseau @bio_clouseau
$ICPT REVERSE trial in Cirrhosis enrollment completion guidance now "early" 2020
January 15th 2020, 1:01pm
EpiscopalianTra @EpiscopalianTra
$ICPT, $PBYI: Big day from JPM healthcare conference
January 15th 2020, 8:01am
smelky_kid @smelky_kid
@DrReddyGI $icpt. Have u read the balance sheet? OCA sales guidance for PBC was raised 3 times this year. It will… https://t.co/cFPn47M81s
January 14th 2020, 10:01pm
DrReddyGI @DrReddyGI
It would be enlightening for $ICPT or other #NASH pharma companies to spend time in a GI clinic to see how patients are evaluated.
January 14th 2020, 8:01pm
DrReddyGI @DrReddyGI
$ICPT will probably encourage doctors to screen for NASH with FIB-4/APRI, but I don't see that happening. I see a… https://t.co/p7gXg5Sv7x
January 14th 2020, 8:01pm
MSollender @MSollender
RT @IanARowe: This is a fascinating insight into the commercial view from $ICPT in #NASH First, will biopsy be required? They think... No…
January 14th 2020, 7:01pm
BIOTECH888 @BIOTECH888
RT @adamfeuerstein: On the cusp of FDA approval for its NASH drug, $ICPT CEO talks payers, pruritis, and price https://t.co/yMdWdD4tcu #JPM…
January 14th 2020, 6:01pm
IanARowe @IanARowe
This is a fascinating insight into the commercial view from $ICPT in #NASH First, will biopsy be required? They t… https://t.co/5GbBHIGLe5
January 14th 2020, 6:01pm
adamfeuerstein @adamfeuerstein
On the cusp of FDA approval for its NASH drug, $ICPT CEO talks payers, pruritis, and price https://t.co/yMdWdD4tcu #JPM20
January 14th 2020, 5:01pm
CentralChartsEN @CentralChartsEN
$ICPT #INTERCEPTPHARMACEUTICALS - Daily: We are currently in a phase of short-term indecision. In a case like this,… https://t.co/Wnn40gq55S
January 14th 2020, 5:01am
Londinia_IA @Londinia_IA
$ICPT #INTERCEPTPHARMACEUTICALS - Daily: We are currently in a phase of short-term indecision. In a case like this,… https://t.co/8QoSnvlMsr
January 14th 2020, 5:01am
CedricCroze @CedricCroze
RT @okim59: B. Riley Boosts Intercept Pharmaceuticals (NASDAQ:ICPT) Price Target to $158.00 $ICPT https://t.co/oaOaS8R9b9
January 14th 2020, 1:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.